Descrizione business
Seagen Inc. is a global biotechnology company that discovers, develops and commercializes transformative cancer medicines to make a meaningful difference in people’s lives. Seagen is headquartered in the Seattle, Washington area, and has locations in California, Canada, Switzerland and the European Union.
Consiglio di amministrazione & Consiglio di sorveglianza
| CEO |
| David R. Epstein |
| Consiglio di amministrazione |
| Felix J. Baker, Todd E. Simpson, Charles Romp, Jean I. Liu, Natasha Hernday, Roger D. Dansey, Vaughn B. Himes, Lee Heeson, Peggy Pinkston, Sherry Pudloski, Lu Chen, William Compton |
| Consiglio di sorveglianza |
| Alpna Seth, Daniel G. Welch, David W. Gryska, John A. Orwin, Nancy A. Simonian, Ted Love, Sandra M. Swain, David R. Epstein |
Dati aziendali
| Name: |
Seagen Inc. |
| Indirizzo: |
21717-30th Drive S.E., Building 3,Bothell, WA 98021, USA |
| Telefono: |
+1-425-527-4000 |
| Fax: |
- |
| E-mail: |
contact@seagen.com
|
| Internet: |
https://www.seagen.com/ |
| Industria: |
Biotechnology |
| Settore: |
Biotechnology |
| Sub settore: |
Biotechnology |
| Fine dell'anno finanziario: |
31/12 |
| Flottante libero: |
- |
| Data dell'IPO: |
01/03/2001 |
Rapporti con gli investitori
| Name: |
Peggy Pinkston |
| IR telefono: |
+1-425-527-4160 |
| IR Fax: |
- |
| IR e-mail: |
investors@seagen.com
|
